课题基金 / 基金详情

Clinical importance of drug-drug-interactions

Clinical importance of drug-drug-interactions
药物相互作用的临床重要性
批准号:
7032605
负责人:
Sean Hennessy
金额:
$47.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2011-08-31

项目摘要

项目成果

Sean Hennessy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Drug-drug interactions (DDIs) are an important public health problem, especially in the elderly, who are the largest consumers of medications. Nearly all existing knowledge about the clinical importance of potential DDIs comes from pharmacokinetic studies or case reports, both of which have limited utility for identifying clinically important DDIs. As a result, there is a great deal of disagreement among standard DDI reference texts regarding the clinical importance of most potential DDIs. Systematic efforts such as drug utilization review programs and computerized physician order entry that seek to improve medication use depend entirely upon a valid set of clinical rules, and are thus severely hampered by this knowledge gap. To address these critical gaps in existing knowledge of the clinical importance of DDIs, the investigators will perform controlled epidemiologic studies of high-priority potential DDIs that have been selected based on a formal process involving consultation with an Expert Panel of clinicians and clinical pharmacologists. We will use and expand upon an existing, very large pharmacoepidemiologic database consisting of Medicaid data from five large programs, supplemented by Medicare data to ensure complete capture of outcomes in the elderly, together with the General Practice Research Database from the UK. We will examine the validity of our outcome measures using medical record review. Our research strategy will include nested case-control and case-crossover designs, and will yield relative risks, risk differences, and number needed to harm (NNH). Patient and treatment factors associated with developing the adverse outcome of interest will be studied. The results of this study will have important implications for public health, clinical care, and the elucidation of the pharmacology of DDIs, and will serve as a basis for future studies examining factors not recorded in administrative and medical records data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
  • 批准号:
    10661090
  • 项目类别:
  • 资助金额:
    $76.24万
  • 财政年份:
    2022
  • 负责人:
    Sean Hennessy
  • 依托单位:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
  • 批准号:
    10501196
  • 项目类别:
  • 资助金额:
    $67.99万
  • 财政年份:
    2022
  • 负责人:
    Sean Hennessy
  • 依托单位:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
  • 批准号:
    10662407
  • 项目类别:
  • 资助金额:
    $36.25万
  • 财政年份:
    2021
  • 负责人:
    Sean Hennessy
  • 依托单位:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
  • 批准号:
    10392130
  • 项目类别:
  • 资助金额:
    $36.25万
  • 财政年份:
    2021
  • 负责人:
    Sean Hennessy
  • 依托单位:
国内基金
海外基金
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
  • 批准号:
    82371603
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈晓
  • 依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
  • 批准号:
    82370743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姜娜
  • 依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
  • 批准号:
    82371585
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    周鲁明
  • 依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮渊
  • 依托单位: